These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 37073669)

  • 41. Comparative beta-adrenoceptor blocking effects of propranolol, bisoprolol, atenolol, acebutolol and diacetolol on the human isolated bronchus.
    Naline E; Sarria B; Ertzbischoff O; Ozanne P; Advenier C
    Br J Clin Pharmacol; 1990 Jul; 30(1):135-9. PubMed ID: 1975197
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Do randomized controlled trials always trump case reports? A second look at propranolol and depression.
    Steffensmeier JJ; Ernst ME; Kelly M; Hartz AJ
    Pharmacotherapy; 2006 Feb; 26(2):162-7. PubMed ID: 16466322
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Every 2nd heart failure patient without beta blocker. "Intolerance" is often a dosage error].
    MMW Fortschr Med; 2003 Feb; 145(6):58. PubMed ID: 12619366
    [No Abstract]   [Full Text] [Related]  

  • 44. Outcomes of beta blocker use in cocaine-associated chest pain: a meta-analysis.
    Pham D; Addison D; Kayani W; Misra A; Jneid H; Resar J; Lakkis N; Alam M
    Emerg Med J; 2018 Sep; 35(9):559-563. PubMed ID: 29921621
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adrenergic urticaria: a new form of stress-induced hives.
    Shelley WB; Shelley ED
    Lancet; 1985 Nov; 2(8463):1031-3. PubMed ID: 2865515
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Possibilities of cardioselective beta - blocker bisoprolol therapy in patients having coronary artery disease and bronchial asthma].
    Grigorieva NY; Ilyushina TP; Yashina EM
    Ter Arkh; 2019 Sep; 91(9):26-31. PubMed ID: 32598811
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Age-related neuroinflammation and pathology in the locus coeruleus and hippocampus: beta-adrenergic antagonists exacerbate impairment of learning and memory in aged mice.
    Evans AK; Park HH; Saw NL; Singhal K; Ogawa G; Leib RD; Shamloo M
    Neurobiol Aging; 2021 Oct; 106():241-256. PubMed ID: 34320462
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bisoprolol-based
    Kang J; More KN; Pyo A; Jung Y; Kim DY; Chang DJ
    Bioorg Med Chem Lett; 2021 Mar; 36():127789. PubMed ID: 33453362
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adrenergic urticaria and rheumatoid arthritis in a patient with melanoma: an intricate medical management.
    Capella GL
    J Drugs Dermatol; 2012 Mar; 11(3):409-12. PubMed ID: 22395595
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Drug Use Evaluation of Beta-Blockers in Medical Wards of Nedjo General Hospital, Western Ethiopia.
    Fekadu G; Bekele F; Bekele K; Hanbisa S; Belay G; Maqbool M
    Cardiovasc Ther; 2020; 2020():2509875. PubMed ID: 32565908
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Beta adrenoceptor subtype binding activity in plasma and beta blockade by propranolol and beta-1 selective bisoprolol in humans. Evaluation with Schild-plots.
    Wellstein A; Belz GG; Palm D
    J Pharmacol Exp Ther; 1988 Jul; 246(1):328-37. PubMed ID: 2839668
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The efficacy and safety of the combination of β-blocker bisoprolol and if inhibitor I(f) ivabradine in patients with stable angina and chronic obstructive pulmonary disease].
    Ageev FT; Makarova GV; Patrusheva IF; Orlova IaA
    Kardiologiia; 2010; 50(10):22-6. PubMed ID: 21118175
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A comparison of the beta1-selectivity of three beta1-selective beta-blockers.
    Nuttall SL; Routledge HC; Kendall MJ
    J Clin Pharm Ther; 2003 Jun; 28(3):179-86. PubMed ID: 12795776
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An infant with localized vasoconstriction following topical propranolol exposure for infantile hemangioma.
    Saerens J; Gutermuth J; Janmohamed SR
    Pediatr Dermatol; 2021 Jan; 38(1):263-264. PubMed ID: 33275306
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Takotsubo cardiomyopathy: a novel beta-adrenergic blocker withdrawal syndrome].
    Tomcsányi J; Jávor K; Arabadzisz H; Zsoldos A; Wagner V; Sármán B
    Orv Hetil; 2013 Feb; 154(7):267-71. PubMed ID: 23395791
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Beta-blocker subtypes and risk of low birth weight in newborns.
    Duan L; Ng A; Chen W; Spencer HT; Lee MS
    J Clin Hypertens (Greenwich); 2018 Nov; 20(11):1603-1609. PubMed ID: 30267456
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bisoprolol versus hydrochlorothiazide plus amiloride in essential hypertension, a randomized double-blind study.
    Honoré P
    Eur Heart J; 1987 Dec; 8 Suppl M():95-102. PubMed ID: 2897305
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The antihypertensive effect of the new cardioselective prolonged-action beta-adrenoblocker bisoprolol compared with propranolol, metoprolol and placebo].
    Metelitsa VI; Duda SG; Gorbunov VM; Buchner-Moll D; Deev AD; Vygodin VA; Filatova NP; Chel'dieva EIa; Shastun RS; Simonov DV
    Eksp Klin Farmakol; 1995; 58(2):32-4. PubMed ID: 7773086
    [TBL] [Abstract][Full Text] [Related]  

  • 59. β-blocker therapy for infantile hemangioma.
    Koh SP; Leadbitter P; Smithers F; Tan ST
    Expert Rev Clin Pharmacol; 2020 Aug; 13(8):899-915. PubMed ID: 32662682
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adrenergic urticaria: review of the literature and proposed mechanism.
    Hogan SR; Mandrell J; Eilers D
    J Am Acad Dermatol; 2014 Apr; 70(4):763-766. PubMed ID: 24373776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.